New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 22, 2013
04:55 EDTABT, ABT, TMO, TMO, SYK, SYK, RHHBY, RHHBY, PFE, PFE, HAE, HAE, FRX, FRX, EW, EW, COV, COV, CERN, CERN, BCR, BCR, ZOLL, ZOLLSociety of Critical Care Medicine to host a conference
42nd Critical Care Congress is being held in San Juan, Puerto Rico on January 19-23.
News For ABT;BCR;CERN;COV;EW;FRX;HAE;PFE;RHHBY;SYK;TMO;ZOLL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
April 17, 2015
05:32 EDTRHHBYAccelerate Diagnostics appoints Pete Bantock to Chief Culture Officer
Accelerate Diagnostics (AXDX) appointed Pete Bantock to the newly created position of Chief Culture Officer and Head of Human Resources. Bantock was most recently the SVP and Head of commercial Operations for the Americas. He will be replaced by Ron Price, who joins the company from Roche (RHHBY) where he held the position of VP of Point of Care and Commercial Operations.
April 16, 2015
08:04 EDTRHHBYRoche granted orphan status for lymphoma treatment
The FDA granted Roche's Genentech unit orphan status for Gazyva, its treatment of follicular lymphoma.
April 15, 2015
08:04 EDTPFEPfizer: PALOMA-3 trial for IBRANCE met primary endpoint, trial stopped early
Subscribe for More Information
07:41 EDTTMO, ABTEBD Group to hold a forum
ChinaBio Partnering Forum 2015 is being held in Shanghai, China on April 15-16.
07:40 EDTCERNCerner price target raised to $83 from $74 at UBS
Subscribe for More Information
April 14, 2015
14:48 EDTSYKZimmer, Stryker have mixed read through from J&J results, says Wells Fargo
Subscribe for More Information
10:24 EDTCERNCerner repeats Q1 adjusted EPS view 44c-45c, consensus 45c
Repeats Q1 revenue view $1.05B-$1.1B, consensus $1.09B.
10:22 EDTCERNCerner repeats FY15 adjusted EPS view $2.05-$2.15, consensus $2.11
Repeats FY15 revenue view $4.8B-$5B, consensus $4.92B. Guidance provided in company slides presentation.
10:16 EDTTMOHigh option volume stocks
High option volume stocks: NSAM ALU CJES BIG CMRX ERIC NTAP TMO KN CIG
09:06 EDTABTAbbott and Sekisui announce collaboration for coagulation testing
Abbott and Sekisui announce an agreement to offer coagulation testing solutions for laboratories worldwide. Coagulation tests measure a person's blood clotting ability, which can help doctors assess risks of excessive bleeding or developing clots. Under the agreement, Abbott will be the exclusive distributor of Sekisui's new CP3000 coagulation instrument in the United States, Europe and other regions that recognize CE Mark.
06:30 EDTRHHBYRoche to seek to have cancer drug tested in 11 trials in 2015, Reuters says
Roche said it would seek to have its immunotherapy cancer drug, MPDL3280A, in 11 late stage trials by the end of 2015, aaccording to Reuters. The drug is being tested in melanoma, as well as lung, bladder, kidney, bowel and blood cancers, the news service noted. Reference Link
April 13, 2015
15:12 EDTPFEMylan enters settlement, license agreement with Pfizer regarding Viagra
Mylan (MYL) announced that its subsidiaries Mylan Inc. and Mylan Pharmaceuticals have entered into a settlement and license agreement with Pfizer (PFE), Pfizer Limited and Pfizer Ireland Pharmaceuticals to settle patent litigation relating to Mylan's Abbreviated New Drug Application filed with the U.S. FDA for Sildenafil Citrate Tablets 25 mg, 50 mg, and 100 mg. This product is the generic version of Viagra, which is indicated to treat erectile dysfunction. Under the terms of the agreement, Mylan will be able to launch its ANDA products pursuant to a royalty-bearing license as early as December 11, 2017, or sooner under certain conditions, subject to FDA approval. All other terms and conditions of the settlement and license agreement are confidential, and the agreement itself is subject to review by the U.S. Department of Justice and the Federal Trade Commission. For the 12 months ending Dec. 31, 2014, Viagra had U.S. sales of approximately $1.3B, according to IMS Health.
10:15 EDTSYKHigh option volume stocks
Subscribe for More Information
10:10 EDTHAEHaemonetics named a long-term Sell at Off Wall Street Research
Subscribe for More Information
10:01 EDTRHHBYRoche acquires CAPP Medical
Roche announced it has acquired CAPP Medical, a genomics research company founded by Stanford University oncologists and industry veterans, to advance the development of technology for cancer screening and monitoring through the detection of circulating tumor DNA in blood.
07:32 EDTCERNCerner, Qualcomm announce home health monitoring collaboration
Cerner (CERN) and Qualcomm Life, a subsidiary of Qualcomm (QCOM), announced an agreement to extend Cerner's medical device connectivity capabilities beyond the hospital to the home. Cerner will leverage Qualcomm Life's FDA listed 2net Platform and Hub to seamlessly capture data from medical devices and sensors within a patient's home, and transmit it to Cerner health care clients through Cerner's CareAware device connectivity platform. Through this initiative, care providers can remotely monitor chronically ill patients in near real-time to enable proactive engagement to potentially reduce the risk of an acute care episode.
07:31 EDTCERNCerner and Qualcomm Life announce collaboration agreement
Cerner (CERN) and Qualcomm Life, a subsidiary of Qualcomm (QCOM), announced an agreement to extend Cerner's industry medical device connectivity capabilities beyond the hospital to the home. Cerner will leverage Qualcomm Life's FDA listed 2net Platform and Hub to seamlessly capture data from medical devices and sensors within a patient's home, and transmit it to Cerner health care clients through Cerner's CareAwareŽ device connectivity platform.
07:31 EDTCERNHealthcare Information & Management Systems Society to hold a conference
HIMSS 2015 is being held in Chicago on April 12-16.
07:29 EDTCERNLeerink to hold booth tours at HIMSS
Subscribe for More Information
April 11, 2015
14:30 EDTCERNCerner to hold a meeting
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use